about
Biomarkers for strokeAdult Stem Cell Therapy for Stroke: Challenges and ProgressInduction of the unfolded protein response and cell death pathway in Alzheimer's disease, but not in aged Tg2576 miceIntravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease.Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice.Circulating mesenchymal stem cells microparticles in patients with cerebrovascular diseaseCancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study.Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease.Brain microangiopathy and macroangiopathy share common risk factors and biomarkers.Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer.Role of high-resolution magnetic resonance imaging in the diagnosis of primary angiitis of the central nervous system.Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway.Cobalt chloride induces neuronal differentiation of human mesenchymal stem cells through upregulation of microRNA-124a.Identification of oxidized serum albumin in the cerebrospinal fluid of ischaemic stroke patients.Enhancing trophic support of mesenchymal stem cells by ex vivo treatment with trophic factors.Albumin therapy in acute stroke patients.Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease.Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells.Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke.Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo.Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya DiseaseApplication of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA StudyMorin Prevents Granule Cell Dispersion and Neurotoxicity via Suppression of mTORC1 in a Kainic Acid-induced Seizure ModelUpregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult BrainNeurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivoBeneficial Effects of Hesperetin in a Mouse Model of Temporal Lobe EpilepsyTherapeutic Potential of AAV1-Rheb(S16H) Transduction Against Alzheimer's Disease
P50
Q27004404-52664819-C810-49F5-B6CF-14D5B921F457Q28066235-BEDC72A2-C944-42B3-ACCC-AFDC11DE6A62Q30494698-2C456096-DBF3-49E3-A846-7C1599551A8FQ33592708-CCFF509C-A1B0-4C51-A243-5A0624FF32A2Q33594766-C08833AF-E1C3-49F2-B001-A52F0AE2BD2DQ34059086-6C3977CF-1D01-48E8-967E-6B7ED129D9B8Q34277653-A21A9FAC-D011-40BA-AC97-6011587FF16BQ36079937-AB6F28EE-241C-4158-9021-B228EE1DE905Q38412128-B63C9A97-9763-4DF1-8965-8A0354F913DFQ38418277-A82FA568-F2FC-4627-9979-5697D02802DDQ38425798-D24AB0F3-EB36-4CAE-8740-967B127D5ED0Q38435987-96117D18-F559-406A-BD9D-733170559E5FQ38436540-1262957B-F4BE-4BBF-BF44-AD2325D19419Q38441710-BD9E327B-FB6C-4421-A5F2-BB4BCFA33B2EQ38477370-7A2BD413-0E77-4C93-A2E0-F19AA79AACB2Q38481406-78DC4C3C-A434-4569-9820-2552B76D9094Q38506339-92D13E84-9FA8-4169-9296-4F1296AE4D62Q38514895-A2CDD40D-1C9B-4389-BD38-8822CA62986BQ47722619-30A532CF-5502-4B33-A225-8DCB4D7B1A88Q50064425-6A57670D-3AB1-443A-8D20-478A74DF0CAFQ50107201-D08581E8-15B3-4593-B465-690180796AF9Q55665217-59C2BB3D-7AF4-4B33-A07B-2F8107ACA0BDQ57789096-AB3D705F-08EC-4CEF-A56D-8E17F4CC38CEQ57811761-C0CD9C9B-2C31-463E-A8B4-B44C6DCD2CB0Q90327922-40BB28E4-B1D4-4544-8F61-EC6843665E2CQ90433673-9763A7CE-BA7A-4537-8AEB-F9EB94D0CBE4Q90971164-27360717-0D09-453E-BD69-6C4B58A851E7Q91098755-34E586E8-9DE3-4B59-9874-DB14280829F3Q91445478-1695BBE8-DDBB-4776-8D7A-C23367C44776
P50
description
researcher ORCID ID = 0000-0002-2851-9563
@en
wetenschapper
@nl
name
Gyeong Joon Moon
@ast
Gyeong Joon Moon
@en
Gyeong Joon Moon
@es
Gyeong Joon Moon
@nl
type
label
Gyeong Joon Moon
@ast
Gyeong Joon Moon
@en
Gyeong Joon Moon
@es
Gyeong Joon Moon
@nl
prefLabel
Gyeong Joon Moon
@ast
Gyeong Joon Moon
@en
Gyeong Joon Moon
@es
Gyeong Joon Moon
@nl
P106
P1153
8323365700
P31
P496
0000-0002-2851-9563